The company was originally incorporated as ‘Remus Pharmaceuticals Private Limited’ as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Later on, pursuant to a special resolution passed by its shareholders in the Extra-Ordinary General Meeting held on January 02, 2023, the company was converted from a private limited company to public limited company and consequently, the name of the company was changed to ‘Remus Pharmaceuticals Limited’, and a fresh certificate of incorporation dated January 06, 2023 was issued to the company by the Registrar of Companies, Ahmedabad. 

The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries. It looks forward to form long lasting relationships that enhance the lives of its patients.

The company is majorly engrossed in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical finished formulations and products. Depending upon business requirements, it gets finished pharmaceutical formulations manufactured on loan license or contract manufacturing. Such manufacturing is on principle to principle basis. It has its presence through registered and/or under registration products in countries namely Bhutan, Bolivia, Chile, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, Vietnam etc. It deals in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Business area of the company

The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient).

Products of the company

• Cardiovascular
• Anti-DIABETIC
• Central nervous system
• Analgesic / Anti-Inflammatory
• Anti-Allergy
• Anti-Infective / Anti biotics 
• Hormonal
• Urology
• Immuno suppressant
• Erectile dysfunction
• Effervescent
• Other formulations

History and milestones

• 2015: The company was incorporated as a private limited company under the name ‘Remus Pharmaceuticals Private Limited’.
• 2023: Conversion of the company from Private Limited to Public Limited Company.